MedPath
HSA Approval

AXCEL CHLORPHENIRAMINE TABLETS 4 mg

SIN10511P

AXCEL CHLORPHENIRAMINE TABLETS 4 mg

AXCEL CHLORPHENIRAMINE TABLETS 4 mg

December 5, 1998

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKOTRA PHARMA MARKETING
Licence HolderKOTRA PHARMA MARKETING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R06AB02

dexchlorpheniramine

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

CHLORPHENIRAMINE MALEATE

4 mg

Chlorpheniramine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AXCEL CHLORPHENIRAMINE TABLETS 4 mg - HSA Approval | MedPath